Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$851,889,084
-$66,141,417 QoQ
Shares Held
4,492,612
-3.5% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#43
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIL Ltd holds $2,310,187,043 across 11 Drug Manufacturers - General names. AZN ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
4,492,612 | $851,889,084 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
6,523,813 | $375,902,104 | |
| 3 | PFE |
Pfizer Inc
|
10,482,713 | $252,423,729 | |
| 4 | LLY |
ELI LILLY & Co
|
201,889 | $242,151,742 | |
| 5 | ABBV |
AbbVie Inc.
|
677,123 | $170,391,231 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
987,104 | $124,710,718 | |
| 7 | JNJ |
Johnson & Johnson
|
431,712 | $109,641,896 | |
| 8 | MRK |
Merck & Co., Inc.
|
678,957 | $87,245,974 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $851,889,084 | 4,492,612 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $918,030,501 | 4,654,855 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||